Icosagen Cell Factory OÜ
Private limited company
- 11107818
- EE100969520
- Tartu maakond, Kambja vald, Õssu küla, Eerika tee 1, 61713
Company Icosagen Cell Factory OÜ has been registered on 15/04/2005. The status of the company is Active.
The number of employees in the company in 2024 was 167. The number of employees has increased compared to 2023
The net sales for 2024 were 12 916 070 euros. The net sales of Icosagen Cell Factory OÜ decreased compared to 2023. The profit margin for 2024 is 7%. It has decreased compared to 2023
The company's activity is .
Empower Your Business
See all our solutions to grow your business
General Information
Company name in the business register
Icosagen Cell Factory OÜ
Previous and other name(s)
Quattromed Cell Factory OÜ
OÜ Rakuvabrik
Company type
Private limited company
Registration number
11107818
D-U-N-S number
360205582
Registered
Apr 15, 2005 over 20 years ago
Registered capital
11,504 EUR
VAT number
EE100969520 from May 18, 2005 over 20 years
Status
Active
Contact data
Physical address
Tartu maakond, Kambja vald, Õssu küla, Eerika tee 1, 61713
Telephone
Fax
E-mail address
Internet address (www)
Quarterly taxes paid
Source: Estonian Tax and Customs Board
Responsible persons
| Name | Personal ID / Date of birth | Role | From |
|---|---|---|---|
| Mart Ustav | 34907×××××× | Management board member | Nov 3, 2008 |
Source: Estonian Business Registry (RIK)
Representation rights
- Every member of the Management Board may represent the private limited company in concluding all transactions.
Source: Estonian Business Registry (RIK)
Shareholders, supervisory board and other persons
D&B Risk Analytics Compliance Intelligence
D&B Risk Analytics Compliance Intelligence provides compliance teams with industry-leading data and modern capabilities to manage third-party compliance risk. Through intelligent and highly configurable policy-based workflows, D&B Risk Analytics Compliance Intelligence provides a state-of-the-art automated KYC/KYB monitoring solution that helps companies stay informed of risks in near real-time.
Product is designed to help compliance teams quickly and efficiently review, assess, monitor, and manage entities and related parties, including beneficial owners and significant control persons.
More information
can be found in
Financial information
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 12 916 070 | ↓-3.24% | 13 347 905 | ↓-2.41% | 13 677 072 | ↑19.08% | 11 485 743 |
| Net profit (loss) | 848 033 | ↓-65.75% | 2 475 854 | ↓-58.51% | 5 967 760 | ↑11.90% | 5 332 983 |
| No of employees | 167 | ↑24.63% | 134 | ↑31.37% | 102 | ↑52.24% | 67 |
What are the company's liabilities, current assets, equity and balance volume?
Dun & Bradstreet Finance Analytics gives you access to additional economic indicators - short-term liabilities, current assets, equity and balance volume. Everything you need for credit risk management across companies of all sizes worldwide.
More information
can be found in